Search
gallium nitrate (Ganite)
Tradename: Ganite.
Indications:
- treatment of symptomatic hypercalcemia of malignancy that has not responded to adquate hydration
Dosage: 200 mg/m2 IV infusion for 5 consecutive days
Injection: 25 mg/mL (20 mL)
Adverse effects:
1) common (> 10%)
- metallic taste, nausea/vomiting, diarrhea, renal toxicity, hypophosphatemia
2) less common (1-10%)
- hypocalcemia
3) uncommon (< 1%)
- anemia, optic neuritis, hearing impairment
4) other
- bone marrow toxicity
General
metabolic agent (metabolic modifier)
Database Correlations
PUBCHEM correlations
References
- Kaiser Permanente Northern California Regional Drug
Formulary, 1998
- Medical Knowledge Self Assessment Program (MKSAP) 11, American
College of Physicians, Philadelphia 1998